CRVS NASDAQ
Corvus Pharmaceuticals, Inc.
1W: -6.2%
1M: -23.2%
3M: -28.1%
YTD: +48.9%
1Y: +50.1%
3Y: +651.7%
5Y: +60.3%
$10.90
-0.03 (-0.27%)
Weekly Expected Move ±7.8%
$9
$10
$11
$12
$13
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-54M
Net Income
-19.9% YoY
$-45M
Free Cash Flow
-56.1% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-35.4%
ROA-32.9%
ROIC-415.6%
Valuation
P/E-17.0
P/B4.5
EV/EBITDA-22.6
Leverage
Debt/Equity0.00
Current Ratio16.16
Interest Cov.-28.9x
Quality Scores
Piotroski F4/9
Altman Z57.10
Beneish M0.00